5,N,N-TMT
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (2-(5-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 22120-39-4 |
| ATC code | ? |
| PubChem | CID 1837 |
| ChemSpider | 1771  |
| Chemical data | |
| Formula | C13H18N2 |
| Mol. mass | 202.30 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
5,N,N-trimethyltryptamine (5,N,N-TMT; 5-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was first made in 1958 by E. H. Young. [1] In animal experiments it was found to be in between DMT and 5-MeO-DMT in potency [2][3] which would suggest an active dosage for humans in the 20–60 mg range. Human psychoactivity for this compound has been claimed in reports on websites such as Erowid but has not been independently confirmed.
[edit] See also
[edit] References
- ^ Young EH, J. Chem. Soc. 3493 (1958)
- ^ Glennon et al., J. Med. Chem. 22:428-432 (1979)
- ^ Glennon RA, Young R, Rosecrans JA, Kallman MJ. Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities.Psychopharmacology (Berlin). 1980 May, 68(2): 155-158
 |
This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
